Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA). This means it works by imitating not one, but two unique incretin hormones produced by the human body. It works by stimulating GLP-1 production in the body, which helps the body produce more insulin when needed. GIP has been shown to decrease food intake & increase energy expenditure therefore resulting in weight reductions & when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose, & lipides. This medication has all the benefits of Semaglutide for weight loss with appetite suppression but it also adds the component of additional fat loss as a GIP.
A Tirzepatide Screening form is required to determine eligibility for our Tirzepatide Therapy.
- Those with personal or family history of thyroid cancer; multiple endocrine neoplasia syndrome type 2; other DM medications, especially insulin & sulfonylureas; history of pancreatitis, history of gall bladder disease; kidney disease; tachycardia; retinopathy; pregnant, breast-feeding, or trying to get pregnant
- Known hypersensitivity to Tirzepatide or to any of the product components
BMI less than 27 will disqualify you from receiving Tirzepatide from Hydrations Wellness per our established protocols.
Clients new to Tirzepatide will need to complete some intake forms prior to beginning their first injection. A Medical review will be completed within 1 business day and you will be notified of your eligibility. You may also complete these forms online if you prefer by CLICKING HERE Upon Approval, you will be required to pay $250/month at the beginning of week 1, week 5, week 9 and week 13 injections. If you discontinue use, no refunds will be able to be given for the month in which you prepaid after the first injection for that month has been given. MAINTENANCE/EXISTING USERS Once you complete your 4 month protocol, you will be able to pay for your maintenance dose injections at time of service. If you are an existing user who started Tirzepatide prior to visiting Hydrations Wellness, you will need to provide a copy of your prescription for verification before receiving your first injection with us. SELF-CARE USERS Clients who have completed at least 4 maintenance does injections may opt to purchase the vial/supplies in order to perform their own injections at home. You will still need to come and pickup your vial/supplies at Hydrations Wellness and prepay prior to having them ordered. No refunds on payment for vial/supplies once the prescription has been submitted to the pharmacy by Hydrations Wellness.
- Based on findings in rats and mice, GLP-1 Receptor Agonists like Semaglutide and Tirzepatide may cause thyroid C-cell tumors, including MTC, in humans as human relevance of Tirzepatide-induced rodent thyroid C-cell tumors has not been determined
- After initiating treatment, monitor for signs and symptoms of pancreatitis (eg, persistent severe abdominal pain, sometimes radiating to the back and which may or may not be accompanied by vomiting); If pancreatitis is suspected, discontinue Tirzepatide and do not restart if confirmed
- Patients treated with Tirzepatide showed an increased risk of diabetic retinopathy complications compared with placebo/comparator; rapid improvement in glucose control has been associated with a temporary worsening of diabetic retinopathy
- Post-marketing reports describe acute kidney injury and worsening of chronic renal failure, which may sometimes require hemodialysis in patients treated with GLP-1 receptor agonists; a majority of reported events occurred in patients who had experienced nausea, vomiting, diarrhea, or dehydration; We may require bloodwork to monitor renal function when initiating or escalating doses of Tirzepatide in patients reporting adverse GI reactions
- Serious hypersensitivity reactions (eg, anaphylaxis, angioedema) have been reported with GLP-1 receptor agonists; if hypersensitivity reactions occur, discontinue treatment, treat promptly, and monitor until signs and symptoms resolve
- nausea,
- vomiting,
- stomach pain,
- loss of appetite,
- diarrhea, and/or constipation
- Belching/Burping
If you experience these side effects, we will lower your dosage to the last dose tolerated without side effects.
Serious/Rare side effects of Tirzepatide include:
- hives,
- itching,
- dizziness,
- fast heartbeats,
- difficult breathing,
- swelling of the face, lips, tongue, or throat,
- vision changes,
- swelling or a lump in the neck,
- trouble swallowing,
- hoarse voice,
- shortness of breath,
- severe pain in your upper stomach spreading to the back,
- nausea with or without vomiting,
- headache,
- hunger,
- weakness,
- sweating,
- confusion,
- irritability,
- dizziness,
- feeling jittery,
- little or no urination,
- swelling in the feet or ankles, and
- tiredness
If you experience serious side effects, seek immediate medical attention. You will no longer be eligible for future injections.
Gliclazide, glipizide, glibenclamide, glimepiride, nateglinide and repaglinide.
These drugs are more likely to cause hypoglycemic events in diabetics who use Tirzepatide for weight loss.
Precautions should be taken when using non-prescription medications as well. Per Mayo Clininc, the medications include:
OTC medicines for: appetite control, asthma, colds, cough, hay fever, or sinus problems.
To qualify for Tirzepatide for weight loss with Hydrations Wellness, your BMI must be 27 or higher.
